Gene therapy strategies for leukemia

Smetsers, 1994, Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173, Leukemia, 8, 129 Smetsers, 1995, Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular Bcr-abl protein levels, Leukemia, 9, 118 Skorski, 1993, Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamide, J. Clin. Invest., 92, 194, 10.1172/JCI116549 Szczylik, 1991, Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides, Science, 253, 562, 10.1126/science.1857987 Ratajczak, 1992, In vivo treatment of human leukemia in a SCID mouse model with c-myb antisense oligodeoxynucleotides, 80, 11823 Skorski, 1995, c-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis, Cancer Res., 55, 2275 Calabretta, 1991, Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging, 88, 2351 Heikkila, 1987, A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1, Nature, 328, 445, 10.1038/328445a0 Ratajczak, 1992, Acute-and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligonudeotides, Blood, 79, 1956, 10.1182/blood.V79.8.1956.1956 Skorski, 1994, Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth, J. Exp. Med., 179, 1855, 10.1084/jem.179.6.1855 Citro, 1992, Inhibition of leukemia cell proliferation by receptormediated uptake of c-myb antisense oligodeoxynucleotides, Proc. Natl. Acad. Sci. U. S. A., 89, 7031, 10.1073/pnas.89.15.7031 O'Brien, 1994, Antisense BCR-ABL oligomers cause nonspecific inhibition of chronic myeloid leukemia cell lines, Leukemia, 8, 2156 Bayever, 1993, Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial, Antisense Res. Dev., 3, 383, 10.1089/ard.1993.3.383 Cornetta, 1992, Safety aspects of gene therapy, Br. J. Haematol., 80, 421, 10.1111/j.1365-2141.1992.tb04552.x Ho, 1991, Non-sequence-specific inhibition of transferrin receptor expression in HL-60 leukemia cells by phosphorothioate oligodeoxynucleotides, Antisense Res. Dev., 1, 329, 10.1089/ard.1991.1.329 Kirkland, 1993, BCR-ABL antisense purging in chronic myeloid leukaemia, Lancet, 342, 614, 10.1016/0140-6736(93)91438-R Tari, 1994, Liposomal delivery of methylphosphonate antisense oligonucleotides in chronic myelogenous leukemia, Blood, 84, 601, 10.1182/blood.V84.2.601.601 Nabel, 1993, Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans, Proc. Natl. Acad. Sci. U. S. A., 90, 11307, 10.1073/pnas.90.23.11307 Haseloff, 1988, Simple RNA enzymes with new and highly specific endoribonuclease activity, Nature, 334, 585, 10.1038/334585a0 Lange, 1993, In vitro and in vivo effects of synthetic ribozymes targeted against BCR/ABL mRNA, Leukemia, 7, 1786 Wright, 1993, Ribozyme-mediated cleavage of the bcr/abl transcript expressed in chronic myeloid leukemia, Exp. Hematol., 21, 1714 Snyder, 1993, Ribozyme-mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line, Blood, 82, 600, 10.1182/blood.V82.2.600.600 Leopold, 1995, Multi-unit ribozyme-mediated cleavage of bcr-abl mRNA in myeloid leukemias, Blood, 85, 2162, 10.1182/blood.V85.8.2162.bloodjournal8582162 Lange, 1994, Comparison of different ribozymes for efficient and specific cleavage of BCR/ABL related mRNAs, FEBS Lett., 338, 175, 10.1016/0014-5793(94)80359-5 Inaba, 1994, DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein, Mol. Cell. Biol., 14, 34003, 10.1128/MCB.14.5.3403 Bielinska, 1990, Regulation of gene expression with double-stranded phosphorothioate oligonudeotides, Science, 250, 997, 10.1126/science.2237444 Chu, 1992, The stability of different forms of double-stranded decoy DNA in serum and nuclear extracts, Nucleic Acids Res., 20, 5857, 10.1093/nar/20.21.5857 Postel, 1991, Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels, 88, 8227 Martiat, 1993, Retrovirally transduced antisense sequences stably suppress p210bcr-abl expression and inhibit the proliferation of BCR/ABL-containing cell lines, Blood, 81, 502, 10.1182/blood.V81.2.502.502 Chen, 1995, Retroviral vectors expressing antisense to the BCR promoter region inhibit human CML cell lines but not primary CD34+ HLA-DR+ cells, Exp. Hematol., 23, 906 Leemhuis, 1993, Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow, Blood, 81, 801, 10.1182/blood.V81.3.801.801 Verfaillie, 1992, Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression, Blood, 79, 1003, 10.1182/blood.V79.4.1003.bloodjournal7941003 Traycoff, 1995, The 30/35 kD chymotryptic fragment of fibronectin enhances retroviral-mediated gene transfer (RMGT) in chronic myelogenous leukemia (CML) CD34+ HLA-DR+ and CD34+ HLA-DR− bone marrow progenitors, Exp. Hematol., 23, 934 Cornetta, 1994, A retroviral vector expressing human interferon γ upregulates MHC antigen expression in human breast cancer and leukemia cell lines, Cancer Gene Ther., 1, 91 Gansbacher, 1990, Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity, Cancer Res., 50, 7820 Cornetta, 1994, Retroviral mediated gene transfer in chronic myelogenous leukemia, Br. J. Haematol., 87, 308, 10.1111/j.1365-2141.1994.tb04914.x Tani, 1995, Development of antileukemia immunity using GM-CSF or B7.1 gene-transduced leukemia cells in vivo in mice, Blood, 86, 1006a Hirst, 1995, Comparison of B7.1 and interleukin-2 (IL-2) in the rejection of a murine myeloid leukemia, Blood, 86, 414a Dranoff, 1993, Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity,, Proc. Natl. Acad. Sci. U. S. A., 90, 3539, 10.1073/pnas.90.8.3539 Horowitz, 1995, New IBMTR/ABMTR slides summarize current use and outcome of allogeneic and autologous transplants, IBMTR Newsletter, 2, 1 Rosenberg, 1990, Gene transfer into humans — immunotherapy of patients with advanced melanoma, using tumor infiltrating lymphocytes modified by retroviral gene transduction, New Engl. J. Med., 323, 570, 10.1056/NEJM199008303230904 Gulati, 1994, Is bone marrow purging proving to be of value?, Oncology, 8, 19 Brenner, 1993, Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients, Lancet, 342, 1134, 10.1016/0140-6736(93)92122-A Brenner, 1993, Gene-marking to trace origin of relapse after autologous bone-marrow transplantation, Lancet, 341, 85, 10.1016/0140-6736(93)92560-G Deisseroth, 1994, Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow transplant in CML, Blood, 83, 3068, 10.1182/blood.V83.10.3068.3068 Heslop, 1996, Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes, Nat. Med., 2, 551, 10.1038/nm0596-551 Tiberghien, 1994, Gancyclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation?, Blood, 84, 1333, 10.1182/blood.V84.4.1333.1333 Bonini, 1995, Immunity against the transgene product may limit efficacy of HSV-Tk-transduced donor peripheral blood lymphocytes after allo-BMT, Blood, 86, 628a McLachlin, 1990, Expression of a human complementary DNA for the multidrug resistance gene in murine hemopoietic precursor cells with the use of retroviral gene transfer, J. Natl. Cancer Inst., 82, 1260, 10.1093/jnci/82.15.1260 Sorrentino, 1992, Selection of drug resistant bone marrow cells in vivo after retroviral transfer of human MDR1, Science, 257, 99, 10.1126/science.1352414 Podda, 1992, Transfer and expression of the human multiple drug resistance gene into live mice, Proc. Natl. Acad. Sci. U. S. A., 80, 9676, 10.1073/pnas.89.20.9676